WCLC2026
Log in
Join the event
Language
Resource center
Contact app support
Legal
Home
PL02.04. Risvutatug Rezetecan (a B7-H3-Directed ADC) Versus Topotecan in Relapsed SCLC: Primary Results of Phase 3 ARTEMIS-008
Sunday, September 13, 2026 9:11 AM to 9:21 AM · 10 min. (Asia/Seoul)
Click Here to Go Back to the Main Session
PL02. Presidential Symposium 1 Including Lectureship Award Presentations
Save to bookmarks
Plenary, Hall D2, 3F
Join the event!
See all the content and easy-to-use features by logging in or registering!
Log in
Join the event
Continue as a guest